Octagon Biotech Opportunities Fund II LP

254900HZRZ6VCWBW7E69

The entity

Status: Active
LEI status: Issued and current
Category: Fund
Legal form: 8888
Jurisdiction: United States
Entity created: April 2, 2026

Address

Country: United States
Legal address: C/O CORPORATION SERVICE COMPANY, 251 LITTLE FALLS DRIVE19808 WILMINGTONUnited States (US-DE)
Head office: C/O Octagon Capital Advisors LP, 654 Madison Avenue10065 New YorkUnited States (US-NY)

Identifier

LEI: 254900HZRZ6VCWBW7E69
Registered: April 7, 2026 at 04:48 PM UTC
Last updated: July 10, 2026 at 02:56 PM UTC
Next renewal: April 7, 2027 at 04:48 PM UTC
Issuer: Bloomberg (5493001KJTIIGC8Y1R12)
Registered with: EDGAR (RA000665)
Identifier: 0002132995
Verified against: EDGAR (RA000665)
Verified as: 0002132995
Corroboration: Confirmed against a public register
GLEIF conformity: Meets the standard

Corporate structure

Owned by

OCTAGON CAPITAL ADVISORS LP
Fund managerUnited States549300LAL4WLS7BIZZ14

Why no parent is reported

No direct parent reportedNo ultimate parent reported: No parent prepares consolidated accounts including it

Machine access

REST: https://lei.online/v1/entities/254900HZRZ6VCWBW7E69This record as JSON.
MCP: https://lei.online/mcpThe same data as an MCP tool.

Start a new search